Beam Therapeutics cuts 100 jobs
The Cambridge firm is the latest biopharma company in Massachusetts to shed workers in what experts describe as one of the industry’s biggest shakeouts in decades.
Stay updated with breaking news from Crispr. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The Cambridge firm is the latest biopharma company in Massachusetts to shed workers in what experts describe as one of the industry’s biggest shakeouts in decades.
Using CRISPR-Cas9, researchers created chickens with increased resistance to avian influenza. But viral mutations arose that may allow replication in human cells.
A new study highlights both the promise and the limitations of gene editing, as a highly lethal form of avian influenza continues to spread around the world.
Plus, has culture come to a standstill?
In portraits by German photographer Herlinde Koelbl, past Nobel laureates convey the essence of their complex research in the palm of their hand.